Andrew M. Allen

Florey Institute & Department of Physiology University of Melbourne

Claim

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 32 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

AI Platform Provides an EDGE and Enables State-of-the-art Identification of Peptide-Hlas for the Development of T Cell Inducing Vaccines

Joshua Klein, Daniel Sprague,Monica Lane,Meghan Hart, Olivia Petrillo,Italo Faria do Valle,Matthew Davis,Andrew Ferguson,Andrew Allen,Karin Jooss,Ankur Dhanik

CANCER RESEARCHno. 6 (2024)

Cited0Views0Bibtex

Supplementary Figure 6 from Discovery of a Mutant-Selective Covalent Inhibitor of EGFR That Overcomes T790M-Mediated Resistance in NSCLC

Annette O. Walter,Robert Tjin Tham Sjin,Henry J. Haringsma,Kadoaki Ohashi,Jing Sun,Kwangho Lee,Aleksandr Dubrovskiy,Matthew Labenski,Zhendong Zhu,Zhigang Wang,Michael Sheets,Thia St Martin,Russell Karp,Dan van Kalken,Prasoon Chaturvedi,Deqiang Niu,Mariana Nacht,Russell C. Petter,William Westlin,Kevin Lin,Sarah Jaw-Tsai,Mitch Raponi,Terry Van Dyke,Jeff Etter,Zoe Weaver,William Pao,Juswinder Singh,Andrew D. Simmons,Thomas C. Harding,Andrew Allen

openalex（2023）

Cited0Views0Bibtex

Supplementary Table 1 from Discovery of a Mutant-Selective Covalent Inhibitor of EGFR That Overcomes T790M-Mediated Resistance in NSCLC

openalex（2023）

Cited0Views0Bibtex

Supplementary Tables 1 Through 4 and Supplementary Figures 1 Through 5 from in Vitro and in Vivo Characterization of Irreversible Mutant-Selective EGFR Inhibitors That Are Wild-Type Sparing

Robert Tjin Tham Sjin,Kwangho Lee,Annette O. Walter,Aleksandr Dubrovskiy,Michael Sheets,Thia St. Martin,Matthew T. Labenski,Zhendong Zhu,Richland Tester,Russell Karp,Aravind Medikonda,Prasoon Chaturvedi, Yixuan Ren,Henry Haringsma,Jeff Etter,Mitch Raponi,Andrew D. Simmons,Thomas C. Harding,Deqiang Niu,Mariana Nacht,William F. Westlin,Russell C. Petter,Andrew Allen,Juswinder Singh

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 10 from Discovery of a Mutant-Selective Covalent Inhibitor of EGFR That Overcomes T790M-Mediated Resistance in NSCLC

openalex（2023）

Cited0Views0Bibtex

Supplementary Table 2 from Discovery of a Mutant-Selective Covalent Inhibitor of EGFR That Overcomes T790M-Mediated Resistance in NSCLC

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 2 from Discovery of a Mutant-Selective Covalent Inhibitor of EGFR That Overcomes T790M-Mediated Resistance in NSCLC

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 4 from Discovery of a Mutant-Selective Covalent Inhibitor of EGFR That Overcomes T790M-Mediated Resistance in NSCLC

crossref（2023）

Cited0Views0Bibtex

Supplementary Table 3 from Discovery of a Mutant-Selective Covalent Inhibitor of EGFR That Overcomes T790M-Mediated Resistance in NSCLC

openalex（2023）

Cited0Views0Bibtex

Abstract 3595:In Vivoacquired Resistance to the Mutant EGFR Inhibitor Rociletinib (CO-1686) is Associated with Activation of the C-Met Pathway

Henry J. Haringsma,Andrew Allen,Thomas C. Harding,Andrew D. Simmons

CANCER RESEARCH（2015）

Cited4Views0Bibtex

Author Statistics

#Papers: 32

#Citation: 1234

H-Index: 7

G-Index: 17

Sociability: 6

Diversity: 2

Activity: 0

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn